Literature DB >> 1949770

Causes and prevention of calcium-containing renal calculi.

R A Sutton1.   

Abstract

Kidney stones are common, and recurrences are the rule. At least 90% of patients with kidney stones probably have some identifiable metabolic risk factor. Effective prophylaxis is often available, but with the relatively low rate of recurrence, compliance with the treatment may be a problem. Studies are required to determine the cost-effectiveness of metabolic investigation and prophylactic therapy versus the possible need for repeated treatment by means of extracorporeal lithotripsy, especially in patients having a first calcium oxalate stone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949770      PMCID: PMC1002977     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  21 in total

Review 1.  Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation.

Authors:  F Coe; J H Parks
Journal:  Kidney Int       Date:  1990-10       Impact factor: 10.612

2.  Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.

Authors:  C Y Pak; K Holt
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

3.  Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid.

Authors:  M Lindsjö; B Fellström; S Ljunghall; B Wikström; B G Danielson
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  Nephrolithiasis and bone involvement in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; T P Jacobs; E S Siris; F Gartenberg; D Seldin; T L Clemens; J P Bilezikian
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

Review 5.  Prevention of calcium stones with thiazides.

Authors:  E R Yendt; M Cohanim
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

6.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

Authors:  B Hess; Y Nakagawa; F L Coe
Journal:  Am J Physiol       Date:  1989-07

7.  Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.

Authors:  D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Thiazide diuretic agents and the incidence of hip fracture.

Authors:  A Z LaCroix; J Wienpahl; L R White; R B Wallace; P A Scherr; L K George; J Cornoni-Huntley; A M Ostfeld
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

9.  Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

Authors:  R Pacifici; M Rothstein; L Rifas; K H Lau; D J Baylink; L V Avioli; K Hruska
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

10.  Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria.

Authors:  G Bianchi; G Vezzoli; D Cusi; T Cova; A Elli; L Soldati; G Tripodi; M Surian; E Ottaviano; P Rigatti
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

View more
  1 in total

1.  How we get stoned.

Authors:  L H Smith
Journal:  West J Med       Date:  1991-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.